Latest Investor Presentation News

Babylon Pump & Power (ASX:BPP) says it has satisfied the conditions attached to its revised NAB debt facilities and has sufficient working capital after completing its recapitalisation. The company is now positioning itself as a focused water-management rental business, although ASX has not yet confirmed when trading will resume.

Tungsten Mining NL’s Pre-Feasibility Study confirms Mt Mulgine as a world-scale tungsten project, targeting first production in mid-2029 with robust economics and low operating costs.

MaxiPARTS upgrades FY26 operating profit guidance to $14.2 million, driven by strong cost control and a $9 million inventory reduction, while bolstering its executive team with key appointments.

Lumos Diagnostics is accelerating the rollout of its rapid FebriDx test in the US, with a top 100 urgent care group deploying across 30+ sites and three tier 1 groups validating the test across 230+ locations.

Toubani Resources (ASX: TRE) has launched the retail tranche of its fully underwritten A$70 million entitlement offer at A$0.30 per share, following a successful institutional raise, to fund the Kobada Gold Mine’s construction and exploration.

Count Limited has received Australian Competition and Consumer Commission clearance for its Oracle Group acquisition and locked in a $116.6 million debt facility with Commonwealth Bank to fund the deal and support growth.

Genesis Minerals confirms Regis Resources will not counter its binding acquisition proposal for Vault Minerals, leaving the path clear for Vault's board to consider Genesis's offer as the superior bid.

Motio Ltd has reported its highest ever monthly revenue in June 2026 alongside strong forward bookings for FY27, underpinned by disciplined capital allocation and scalable growth.

Centuria Capital Group has launched the retail component of its $100 million entitlement offer, aiming to raise approximately $35 million. The equity raising supports expansion in AI infrastructure and real estate funds management.

Island Pharmaceuticals is accelerating development of its broad-spectrum antiviral Galidesivir, progressing clinical, regulatory, and manufacturing milestones under the FDA Animal Rule pathway with expanded USAMRIID collaboration and biodefence positioning.

Li-FT Power Ltd. has released an extensive update to its Corporate Governance Statement, outlining its board structure, committee roles, and compliance with Canadian and ASX governance standards. The company highlights partial adherence to some ASX recommendations, reflecting its current development stage.

Blackpearl Group has posted a record 114% jump in Annual Recurring Revenue to NZD 26.8 million, powered by its Pearl Engine vertical AI model that benchmarks 25 times better than leading generalist AI. Despite deepening losses, the firm targets balanced growth and cash conversion in FY27.